Cite
MLA Citation
F. Patriarca et al.. “Prognostic factors and outcome of Epstein–Barr virus DNAemia in high‐risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.” Transplant infectious disease, vol. 15, no. 3, 2013, pp. 259–267. http://access.bl.uk/ark:/81055/vdc_100024497125.0x000030